SATELLOS

Serial Number 98207571
654

Registration Progress

Application Filed
Oct 3, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

SATELLOS

Basic Information

Serial Number
98207571
Filing Date
October 3, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
654
Status Date
Apr 22, 2025
Application
Pending
Classes
005 042

Rights Holder

Satellos Bioscience Inc.

03
Address
200 Bay Street, South Tower, Suite 2800
Toronto M5J2J3
CA

Ownership History

Satellos Bioscience Inc.

Original Applicant
03
Toronto CA

Legal Representation

Attorney
Susan Piascik Christoff

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

26 events
Date Code Type Description Documents
Jul 18, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 18, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 18, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jul 18, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 18, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 18, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 22, 2025 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Apr 14, 2025 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Apr 14, 2025 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Apr 2, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 1, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 2, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Oct 2, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 2, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 30, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 30, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 30, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 31, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 31, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 31, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 23, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 2, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 2, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 2, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 12, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 6, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and biological preparations for treating and managing Duchenne muscular dystrophy and muscle diseases; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing musculoskeletal diseases, disorders, and conditions; Pharmaceutical and biological preparations for promoting the regeneration and repair of damaged muscle tissue; Pharmaceutical and biological therapeutic agents for restoring muscle stem cell repair mechanisms and improving muscle functionality
Class 042
Research and development in the fields of pharmaceutical and biologics; medical and scientific research and development in the field of muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Providing medical and scientific research information in the fields of pharmaceuticals, biologics, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions

Classification

International Classes
005 042